4//SEC Filing
New York & Company, Inc. 4
Accession 0001179110-14-014097
CIK 0001211351operating
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 5:39 PM ET
Size
8.4 KB
Accession
0001179110-14-014097
Insider Transaction Report
Form 4
Finnegan Kevin
EVP, Global Sales & Operations
Transactions
- Award
Common Stock
2014-08-25+20,749→ 109,463 total - Award
Stock Appreciation Rights
2014-08-25+110,034→ 110,034 totalExercise: $3.47Exp: 2024-08-25→ Common Stock (110,034 underlying)
Holdings
- 4,372(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The reporting person was awarded restricted stock which vests on August 25, 2017.
- [F2]Includes 62,000 shares of common stock; 2,248 vested deferred stock units; 382 deferred stock units which vest on August 21, 2016; 1,866 deferred stock units which vest on March 13, 2017; 10,000 shares of restricted stock which vest on April 16, 2015; 12,218 shares of restricted stock which vest on August 26, 2016; and 20,749 shares of restricted stock which vest on August 25, 2017.
- [F3]Represents common stock indirectly beneficially owned through the Kevin L. Finnegan 2004 Grantor Retained Annuity Trust.
- [F4]The reporting person was awarded stock appreciation rights (SARs) which vest as follows: 27,508 on August 25, 2015, 27,508 on August 25, 2016, and 55,018 on August 25, 2017. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.
Documents
Issuer
New York & Company, Inc.
CIK 0001211351
Entity typeoperating
Related Parties
1- filerCIK 0001211351
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 5:39 PM ET
- Size
- 8.4 KB